Document: Concept paper on the guideline revision on good pharmacogenomic practice-2025/12/9

Document: Consolidated 3-year rolling work plan for the Methodology Working Party 2026-2028-2026/1/21

Document: List of medicinal products under additional monitoring-2026/2/25

Page: Post-authorisation efficacy studies: questions and answers-2026/3/27

国家药监局药审中心关于发布《重组胰岛素类产品药学研究与评价技术指导原则（修订版）》的通告（2026年第32号）-2026/5/8

Scientific guideline: ICH M11 guideline, clinical study protocol template and technical specifications - Step 2b-2022/10/26

Regulatory and procedural guideline: European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with track changes-2023/4/25

Draft Guidance: Diabetic Foot Infections: Developing Drugs for Treatment-2023/10/13

Document: Policy 58: European Medicines Agency policy on the handling of competing interests of Management Board members - As adopted by EMA Management Board on 11-12 December 2024-2025/1/14

Page: Worksharing: questions and answers-2025/2/18